2009 European (IUSTI/WHO) Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults

GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Programme (GRASP) Year 2007 report. London: Health Protection Agency 2008. (www.hpa.org.uk/infections/topics_az/hiv_and_sti/sti-gonorrhoea/publications/GRASP_2008_Annual_Report.pdf)

Risley CL , Ward H , Choudhury B , Bishop CJ , Fenton KA , Spratt BG. Geographical and demographic clustering of gonorrhoea in London. Sex Transm Infect 2007; 83: 481–7

Hook EW III , Handsfield H. Gonococcal infections in the adult. Chapter 32 in Holmes KK , Mårdh PA , Sparling PF . (eds)., Sexually Transmitted Diseases. New York: McGraw-Hill, 1999

Sherrard J , Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996; 72: 422–6

Lewis DA , Bond M , Butt KD , Smith CP , Shafi MS , Murphy SM. A one-year survey of gonococcal infection seen in the genitourinary medicine department of a London district general hospital. Int J STD AIDS 1999; 10: 588–94

Barlow D , Phillips I. Gonorrhoea in women: diagnostic, clinical and laboratory aspects. Lancet 1978; i: 761–4

Kent CK , Chaw JK , Wong W. Pevalence of rectal, urethral and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California 2003. Clin Infect Dis 2005; 41: 67–74

Jephcott AE. Microbiological diagnosis of gonorrhoea. Genitourin Med 1997; 73: 245–52

Cook RL , Hutchison SL , Østergaard L , Braithwaite RS , Ness RB. Systematic review: non-invasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142: 914–25

Van Dyck E , Ieven M , Pattyn S , Van Damme L , Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests. J Clin Microbiol 2001; 39: 1751–6

Ison C. GC NAATs: is the time right? Sex Transm Infect 2006; 82: 515

HPS, Scottish Bacterial STIs Reference Laboratory. Guidance on the Introduction of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories. Available at: http://www.documents.hps.scot.nhs.uk/labs/sngrl/naata-2007-08.pdf (last accessed 1 August 2007)

Smith DW , Tapsall JW , Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell 2005; 29: 358–65

Page-Shafer K , Graves A , Kent C , Bals JE , Zapitz VM , Klausner JD. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonrrhoea in men who have sex with men. Clin Infect Dis 2002; 34: 173–6

McNally LP , Templeton DJ , Jin F. Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men. Clin Infect Dis 2008; 47: e25–7

Center for Disease Control and prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections − 2002. MMWR 2002; 51: No. RR-15

Ghanem M , Radcliffe K , Allan P. The role of urethral samples in the diagnosis of gonorrhoea in women. Int J STD AIDS 2004; 15: 45–7

Martin IMC , Hoffman S , Ison CA. European surveillance of sexually transmitted infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 2006; 58: 587–93

Herida M , Desenclos J-D , Martin IMC , Goulet V , Laurent E , Sednaoui P. Increase of Neisseria gonorrhoeae ciprofloxacin resistance in France in 2001-2003. Sex Transm Dis 2006; 33: 6–7

Tapsall JW. Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis 2005; 41: S263–8

Newman LM , Moran JS , Workowski KA. Update on the management of gonorrhoea in adults in the United States. Clin Infect Dis 2007; 44: S84–101

Tapsall J. Current concepts in the management of gonorrhoea. Expert Opin Pharmacother 2002; 3: 147–57

Health Protection Agency. Health Protection Report 2008; 2: No 14 (4 April)

Tapsall JW , Schultz TR , Limnios EA , Donovan B , Lum G , Mulhall BP. Failure of azithromycin therapy in gonorrhoea and discorrelation with laboratory parameters. Sex Transm Dis 1998; 25: 505–8

Young H , Moyes A , McMillan A. Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int J STD AIDS 1997; 8: 299–302

Moran JS , Levine WC. Drugs of choice in the treatment of uncomplicated gonococcal infection. Clin Infect Dis 1995; 20 (Suppl. 1): S47–65

British Association for Sexual Health and HIV. CEG Guideline: Management of gonorrhoea in adults 2005. (www.bashh.org/guidelines/ceguidelines.htm)

Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. Gonorrhoea. MMWR 2006; 55 (No. RR-11): (www.cdc.gov/std/treatment)

Novak E , Paxton LM , Tubbs HJ , Turner LF , Keck CW , Yatsu J. Orally administered cefpodoxime proxetil for the treatment of uncomplicated gonococcal urethritis in males: a dose-response study. Antimicrob Agents Chemother 1992; 36: 1764–5

Ison CA , Mouton JW , Jones K , Fenton KA , Livermore DA. Which cephalosporin for gonorrhoea? Sex Transm Infect 2004; 80: 386–8

Moran JS. Ciprofloxacin for gonorrhea − 250 mg or 500 mg? Sex Transm Dis 1996; 23: 165–7

Handsfield HH , Dalu ZA , Martin DH. Multicenter trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhoea. Sex Transm Dis 1994; 21: 107–11

Moran JS. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Transm Dis 1995; 22: 39–47

Ramus RM , Sheffield JS , Mayfield JA , Wendel GD. A randomised trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhoea in pregnancy. Am J Obstet Gynecol 2001; 185: 629–32

Thompson SE. Treatment of disseminated gonococcal infections. Sex Transm Dis 1979; 6 (Suppl. 1): 181–4